Biocryst Pharmaceuticals BCRX SEC Filings

NASDAQ BCRX
$9.18 +0.11 (+1.21%)
As of: Sep 9, 2026 · 2:49 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Biocryst Pharmaceuticals Inc (BCRX) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index